CALEY DOUGHERTY: Open Payments
NPI 1396256491 · PITTSFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 32 payments from 10 companies in 2025. Trend: 2023 $826 · 2024 $849 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $175 |
| Novartis Pharmaceuticals Corporation | 7 | $165 |
| GENZYME CORPORATION | 5 | $126 |
| Sun Pharmaceutical Industries Inc. | 3 | $74 |
| UCB, Inc. | 2 | $57 |
| Galderma Laboratories, L.P. | 2 | $36 |
| Incyte Corporation | 1 | $24 |
| Amgen Inc. | 1 | $24 |
| Botanix SB Inc | 1 | $22 |
| PFIZER INC. | 1 | $16 |
Products named: COSENTYX, DUPIXENT, SKYRIZI, RINVOQ, Bimzelx, ILUMYA, NEMLUVIO, Winlevi.
Industry payments across NY — which companies pay providers there.
